GRAIL, Inc. (GRAL) Executive Compensation
GRAIL, Inc. (GRAL) is a publicly traded company on the Nasdaq, categorized under SIC 8071 (Services-Medical Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GRAL
CIK: 1699031
Exchange: Nasdaq
SIC 8071: Services-Medical Laboratories
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerJoseph Muscat
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-15 | FORM 4 | 0001628280-26-066150 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-10-15 | FORM 4 | 0001628280-26-066149 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-10-15 | FORM 4 | 0001628280-26-066148 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-10-15 | FORM 4 | 0001628280-26-066147 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001950047-26-010275 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | FORM 4 | 0001628280-26-065365 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-05 | FORM 4 | 0001628280-26-065364 | View SEC Doc Filr Page |
| 144 | 2026-10-05 | — | 144 Filing | 0001628280-26-065140 | View SEC Doc Filr Page |
| 144 | 2026-10-05 | — | 144 Filing | 0001628280-26-065138 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-21 | FORM 4 | 0001628280-26-063234 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-21 | FORM 4 | 0001628280-26-063233 | View SEC Doc Filr Page |
| 144 | 2026-09-21 | — | 144 Filing | 0001950047-26-009717 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-27 | FORM 4 | 0001628280-26-059682 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-27 | FORM 4 | 0001628280-26-059681 | View SEC Doc Filr Page |
| 144 | 2026-08-27 | — | 144 Filing | 0001950047-26-008780 | View SEC Doc Filr Page |
| 144 | 2026-08-27 | — | 144 Filing | 0001950047-26-008758 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000908834-26-000399 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000474 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000763212-26-000026 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001628280-26-054307 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001628280-26-053341 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-28 | — | SCHEDULE 13G/A Filing | 0002012383-26-002582 | View SEC Doc Filr Page |
| 4 | 2026-07-16 | 2026-07-15 | FORM 4 | 0001628280-26-048488 | View SEC Doc Filr Page |
| 4 | 2026-07-16 | 2026-07-15 | FORM 4 | 0001628280-26-048487 | View SEC Doc Filr Page |
| 4 | 2026-07-16 | 2026-07-15 | FORM 4 | 0001628280-26-048486 | View SEC Doc Filr Page |